Ana R. M.
- Country
- Spain
- Department
- 201: Pediatric Unit
Research Overview
- Phase 3 Study to Evaluate the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Tolerability of MRM-3379 in Male Participants with Fragile X Syndrome
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Rugonersen in Angelman Syndrome Patients
Data & Insights
Has run more than one trial at 10 of 40 partner sites.
Specializations
Neurogenetic Disorders
This investigator specializes in the study and treatment of Angelman Syndrome, a rare genetic condition affecting neurological development. Their research encompasses comprehensive therapeutic approaches for managing this complex disorder.
- Genetic Neurological Conditions
- Pediatric Neurological Disorders
- Developmental Disabilities
The investigator's work focuses on evaluating novel therapeutic agents for treating Angelman Syndrome, particularly examining their effects on cognitive function.
Clinical Pharmacology
Expertise in studying the pharmacokinetics and pharmacodynamics of experimental treatments for neurological conditions. The investigator evaluates the safety profiles and therapeutic potential of innovative compounds.
- Drug Safety Assessment
- Therapeutic Monitoring
- Long-term Treatment Effects
Their research includes investigating both acute and long-term safety aspects of therapeutic interventions in neurogenetic disorders.
Pediatric Therapeutics
The investigator has developed expertise in pediatric clinical research, with a particular emphasis on evaluating treatments for genetic neurological conditions in young patients.
- Pediatric Drug Development
- Cognitive Function Assessment
- Treatment Safety in Children
Their work involves evaluating innovative therapeutic approaches specifically designed for pediatric populations with genetic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.